Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasonex in SAR and Concomitant Asthma
NCT00070707Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2003
- Primary completion
- Nov 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR), asthma, sponsored by Organon & Co.. Started Apr 2003; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)asthma
Beyond the preview
Go deeper on NCT00070707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070707.